MUMBAI, India, Aug. 22 -- Intellectual Property India has published a patent application (202517051282 A) filed by Boehringer Ingelheim International Gmbh, Ingelheim am Rhein, Germany, on May 28, for 'novel substituted pyrazine-carboxamide-imidazopyridine derivatives.'
Inventor(s) include Pfau, Roland; Dahmann, Georg; Gerlach, Kai; Giovannini, Riccardo; Du Hoffmann, Johann Faustus; Hohn, Christoph; Just, Stefan; Sommer, Heiko; and Specker, Christian.
The application for the patent was published on Aug. 22, under issue no. 34/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to compounds of formula( I), a process for their manufacture, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of conditions having an association with the function of metabotropic glutamate receptor subtype 4 (mGluR4). A, Xa, Xb, Xc, Xd, A, R1 and R6 have meanings given in the description."
The patent application was internationally filed on Dec. 08, 2023, under International application No.PCT/EP2023/084851.
Disclaimer: Curated by HT Syndication.
